FDA Variance Application from William Moore - Public Comment
Summary
The FDA is accepting public comments on a variance application submitted by William Moore. The comment period is open until March 13. This action pertains to a specific application for a variance.
What changed
The Food and Drug Administration (FDA) is seeking public comment on a variance application submitted by William Moore. The application details are available for review, with a redacted version provided for public access. The FDA's Center for Devices and Radiological Health (CDRH) is listed as an author.
Interested parties are invited to submit comments on this variance application. The deadline for submitting comments is March 13. While the specific nature of the variance is not detailed in the provided text, regulated entities, particularly those in the drug and medical device sectors, should review the application and consider submitting comments if relevant to their operations.
What to do next
- Review the variance application from William Moore.
- Submit comments to the FDA by March 13 if relevant.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 2
Variance Application from William Moore
Restricted: Personally Identifiable Information
More Information
- Author(s) CDRH
Variance Application from William Moore_Redacted
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.